MindMaze Therapeutics Holding SA

OTCPK:RLFT.F Stock Report

Market Cap: US$32.8m

MindMaze Therapeutics Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RLFT.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,075,2224.64%
General Public18,364,67512%
Institutions18,837,42012.3%
VC/PE Firms21,983,94714.4%
Private Companies86,340,78056.6%

Dilution of Shares: RLFT.F only recently listed within the past 12 months

Top Shareholders

Top 20 shareholders own 87.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.9%
Flow Enterprises SA
35,000,000US$7.5m0%no data
19.7%
Bfg Partners International Ltd
30,113,860US$6.5m0%no data
14.4%
Global Emerging Markets
21,983,947US$4.7m707%84.26%
7.54%
Relief Therapeutics International Sa
11,503,909US$2.5m77.7%no data
6.37%
Neuro.io Group SA
9,723,011US$2.1m0%no data
4.86%
First Sentier Investors (Australia) IM Ltd
7,417,725US$1.6m-51.7%no data
4.16%
Salica Investments Limited
6,342,000US$1.4m0%100.0%
3.41%
Thomas Bieri-Eugster
5,200,000US$1.1m0%no data
3.04%
Concord Health Partners, LLC
4,638,620US$996.0k0%100.0%
0.46%
Walid Hanna
700,000US$150.3k0%no data
0.37%
Michael Stunkel
560,000US$120.2k0%no data
0.16%
Martin Reiss
249,000US$53.5k0%no data
0.16%
BlackRock, Inc.
244,896US$52.6k0%no data
0.15%
Olaf Blanke
225,870US$48.5k0%no data
0.13%
UBS Asset Management AG
193,669US$41.6k507%no data
0.087%
Giorgio Reiner
133,000US$28.6k0%no data
0.0046%
Peter de Svastich
7,001US$1.5k0%no data
0.00028%
State Street Global Advisors, Inc.
433US$91.80%no data
0.00023%
Jeremy Meinen
351US$75.40%no data
0.00005%
Horizon Financial Services, LLC
77US$16.40%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/13 18:30
End of Day Share Price 2026/07/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MindMaze Therapeutics Holding SA is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jyoti PrakashEdison Investment Research